Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1184407184
总结
TPMT intermediate metabolizers is associated with increased likelihood of adverse events when treated with azathioprine, mercaptopurine or purine analogues in people with Inflammatory Bowel Diseases as compared to TPMT *1/*1.